Core A: Administrative

项目总结 行政、宣传、规划和沟通核心(行政核心-核心A)的作用是 协调和整合达纳-法伯/哈佛癌症中心(DF/HCC)的多个组成部分 为乳癌孢子项目提供科学、行政和财政监督， CORES、发展研究计划(DRP)和职业提升计划(CEP)。 行政管理：核心A将促进DF/CC内部乳房孢子的协调，以 满足我们的科学目标。核心A将为乳房的财政和行政监督提供基础设施 癌症孢子，包括财务会计和报告，协调研究协议和前期和 与达纳-法伯赠款管理办公室密切合作，进行获奖后监测和报告 癌症研究所。 临床研究管理：核心A将支持所有研究人员在乳房孢子进行临床 试验并促进在临床研究的准备、审查和激活方面的互动和合作 在DF/HCC乳房计划内和外部站点。 孢子在DF/HCC内的整合：核心A将促进孢子之间的协调和沟通 调查人员、食品和药物管理局及其领导、食品和药物管理局乳房方案及其设立的委员会 支持临床试验的开发、审查、激活和管理，以及访问和使用 生物制品和相关的临床数据。核心A将协调共享资源领导委员会 由核心董事、项目负责人、患者权益倡导者和DF/HCC调查人员组成，以及月刊 正在进行的研究会议，经常更新乳房孢子的进展情况。 患者倡导：核心将整合我们大型和高度互动的患者倡导的工作 委员会参与乳房孢子的规划和评估，由教育署署长伊丽莎白·弗兰克指导，AS CORE A的合作调查员。CORE将寻求在四个孢子项目中充分吸引患者权益倡导者， DRP、CEP和核心，以确保在 临床/转化性研究。 规划和评估：核心A将为孢子提供严格的科学领导和监督 项目、核心、DRP和CEP。核心A将组织乳孢子对外会议 咨询委员会(EAB)和内部咨询委员会(IAB)，以评估以下方面的结果和进展 乳孢子。

PROJECT SUMMARY The role of the Administration, Advocacy, Planning and Communication Core (Administrative Core - Core A) is to coordinate and integrate the multiple components of the Dana-Farber/Harvard Cancer Center (DF/HCC) Breast Cancer SPORE and to provide scientific, administrative and fiscal oversight of the SPORE Projects, Cores, the Developmental Research Program (DRP) and the Career Enhancement Program (CEP). Administrative Management: Core A will facilitate the coordination of the Breast SPORE within the DF/HCC to meet our scientific aims. Core A will provide the infrastructure for fiscal and administrative oversight for the Breast Cancer SPORE, including financial accounting and reporting, coordination of research agreements and pre-and post-award monitoring and reporting in close collaboration with the grants management office at Dana-Farber Cancer Institute. Clinical Research Management: Core A will support all investigators in the Breast SPORE conducting clinical trials and facilitate the interaction and collaborations in the preparation, review and activation of clinical studies within the DF/HCC Breast Program and external sites. Integration of SPORE within DF/HCC: Core A will promote coordination and communication between SPORE investigators, the DF/HCC and its leadership, the DF/HCC Breast Program and its established committees that support clinical trial development, review, activation and management, as well as access and use of biospecimens and associated clinical data. Core A will coordinate the Shared Resources Leadership Committee comprised of the core directors, project leaders, patient advocates and DF/HCC investigators, as well as monthly Research-in-Progress meetings for frequent updates on progress in the Breast SPORE. Patient Advocacy: The Core will integrate the work of our large and highly interactive Patient Advocacy Committee into the planning and evaluation of the Breast SPORE, with guidance from Elizabeth Frank, EdM, as co-investigator of Core A. The Core will seek to fully engage the patient advocates in the four SPORE Projects, the DRP, the CEP and the Cores to ensure that the patient perspective is taken into account in the clinical/translational research. Planning and Evaluation: Core A will provide rigorous scientific leadership and oversight for the SPORE Projects, the Cores, the DRP and the CEP. Core A will organize meetings of the Breast SPORE External Advisory Board (EAB) and Internal Advisory Board (IAB) for evaluation on findings and progress across the Breast SPORE.